...
首页> 外文期刊>Neurology. >Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States
【24h】

Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States

机译:影响癫痫COVID-19流行的中心实践在美国

获取原文
获取原文并翻译 | 示例
           

摘要

Persons with epilepsy, especially those with drug resistant epilepsy (DRE), may benefit from inpatient services such as admission to the epilepsy monitoring unit (EMU) and epilepsy surgery. The COVID-19 pandemic caused reductions in these services within the US during 2020. This article highlights changes in resources, admissions, and procedures among epilepsy centers accredited by the National Association of Epilepsy Centers (NAEC). We compared data reported in 2019, prior to the COVID-19 pandemic, and 2020 from all 260 level 3 and level 4 NAEC accredited epilepsy centers. Data were described using frequency for categorical variables and median for continuous variables and were analyzed by center level, center population category, and geographical location. Qualitative responses from center directors to questions regarding the impact from COVID-19 were summarized utilizing thematic analysis. Responses from the NAEC center annual reports as well as a supplemental COVID-19 survey were included. EMU admissions declined 23% (-21,515) in 2020, with largest median reductions in level 3 centers [-55 admissions (-44%)] and adult centers [-57 admissions (-39%)]. The drop in admissions was more substantial in the East North Central, East South Central, Mid Atlantic, and New England US Census divisions. Survey respondents attributed reduced admissions to re-assigning EMU beds, restrictions on elective admissions, reduced staffing, and patient reluctance for elective admission. Treatment surgeries declined by 371 cases (5.7%), with the largest reduction occurring in VNS implantations [-486 cases (-19%)] and temporal lobectomies [-227 cases (-16%)]. All other procedure volumes increased, including a 35% (54 cases) increase in corpus callosotomies. In the US, access to care for persons with epilepsy declined during the COVID-19 pandemic in 2020. Adult patients, those relying on level 3 centers for care, and many persons in the eastern half of the US were most affected.
机译:癫痫的人,特别是那些药物抗癫痫(DRE),可能会从中受益住院服务,如录取癫痫监控单元(EMU)和癫痫手术。这些服务在美国在2020年。文章强调资源的变化,招生,和程序在癫痫中心协会的认可癫痫中心(NAEC)。报道,2019年,COVID-19流行前,260年和2020年从所有三级和四级NAEC认证癫痫中心。为分类变量和使用频率中值为连续变量,进行了分析中心,中心人口类别地理位置。中心董事有关的问题综述了影响COVID-19利用专题分析。年度报告以及补充COVID-19调查包括在内。2020年(-21515年),大值降低在三级中心招生(-44%)[-55]成人中心招生(-39%)[-57]。在东招生更加充实北中部,东部南部中部,中部大西洋,新英格兰和美国人口普查部门。受访者认为减少招生重新分配EMU床,选择性的限制招生、减少人员和病人不愿为选择性入学。手术减少了371例(5.7%),与最大的减少发生在迷走神经刺激法植入-486例(-19%)和颞叶切除术-227例(-16%)。增加,其中包括(54例)增长35%语料库callosotomies。用于癫痫的人拒绝在COVID-19 2020年流感大流行。依靠三级护理中心,许多人在美国的东部受到影响。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号